CagA in Barrett's oesophagus in Colombia, a country with a high prevalence of gastric cancer

Journal of Clinical Pathology

Volumn 58, Issue 3, 2005, Pages 259-262

  Kudo, M ^b,c   Gutierrez, O ^d   El Zimaity, H M T ^a,b   Cardona, H ^d   Nurgalieva, Z Z ^b   Wu, J ^b   Graham, D Y ^b  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

CAGA PROTEIN; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; CAGA PROTEIN, HELICOBACTER PYLORI;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; BARRETT ESOPHAGUS; COLOMBIA; CONTROLLED STUDY; FEMALE; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; STOMACH BIOPSY; STOMACH CANCER; ANIMAL; CHEMISTRY; CLASSIFICATION; ETHNOLOGY; GASTRITIS; HELICOBACTER INFECTION; METAPLASIA; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; PRECANCER; RABBIT; STOMACH MUCOSA; STOMACH TUMOR;

ADULT; AGED; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BARRETT ESOPHAGUS; COLOMBIA; FEMALE; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METAPLASIA; MIDDLE AGED; PRECANCEROUS CONDITIONS; PREVALENCE; RABBITS; STOMACH NEOPLASMS;

EID: 15044347049     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2004.022251     Document Type: Article

References (45)

1. Falk GW. Reflux disease and Barrett's esophagus. Endoscopy 1999;31:9-16.
2. Cameron AJ. Epidemiology of Barrett's esophagus and adenocarcinoma. Dis Esophagus 2002;15:106-8.
3. El-Serag HB. The epidemic of esophageal adenocarcinoma. Gastroenterol Clin North Am 2002;31:421-40, viii.
4. El-Serag HB, Mason AC, Petersen N, et al. Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut 2002;50:368-72.
5. Genta RM, Huberman RM, Graham DY. The gastric cardia in Helicobacter pylori infection. Hum Pathol 1994;25:915-19.
6. Graham DY. Helicobacter pylori is not and never was " protective" against anything, including GERD. Dig Dis Sci 2003;48:629-30.
7. Graham DY. Campylobacter pylori and Barrett's esophagus. Mayo Clin Proc 1988;63:1258-60.
8. Blaser MJ, Perez-Perez GI, Lindenbaum J, et al. Association of infection due to Helicobacter pylori with specific upper gastrointestinal pathology. Rev Infect Dis 1991;13(suppl 8):S704-8.
9. Csendes A, Smok G, Cerda G, et al. Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophageal reflux, erosive esophagitis or Barrett's esophagus. Dis Esophagus 1997;10:38-42.
10. Henihan RD, Stuart RC, Nolan N, et al. Barrett's esophagus and the presence of Helicobacter pylori. Am J Gastroenterol 1998;93:542-6.
11. Kogan Z, Corti R, Cabane A, et al. Helicobacter pylori in Barrett esophagus. Acta Gastroenterol Latinoam 1992;22:215-19.
12. Laheij RJ, van Rossum LG, de Boer WA, et al. Corpus gastritis in patients with endoscopic diagnosis of reflux oesophagitis and Barrett's oesophagus. Aliment Pharmacol Ther 2002;16:887-91.
13. Graham DY. The changing epidemiology of GERD: geography and Helicobacter pylori. Am J Gastroenterol 2003;98:1462-70.
14. Graham DY, Yamaoka Y. H. pylori and cagA: relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications, Helicobacter 1998;3:145-51.
15. Graham DY, Malaty HM, Evans DG, et al. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology 1991;100:1495-501.
16. Shiotani A, Graham DY. Pathogenesis and therapy of gastric and duodenal ulcer disease. Med Clin North Am 2002;86:1447-66.
17. Quddus MR, Henley JD, Sulaiman RA, et al. Helicobacter pylori infection and adenocarcinoma arising in Barrett's esophagus. Hum Pathol 1997;28:1007-9.
18. Vaezi MF, Falk GW, Peek RM, et al. CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus. Am J Gastroenterol 2000;95:2206-11.
19. Loffeld RJ, Werdmuller BF, Kuster JG, et al. Colonization with cagA-positive Helicobacter pylori strains inversely associated with reflux esophagitis and Barrett's esophagus. Digestion 2000;62:95-9.
20. Vicari JJ. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology 1998;115:50-7.
21. Breuer T, Malaty HM, Graham DY. The epidemiology of H. pylori-associated gastroduodenal diseases. In, Ernst P, Michetti P, Smith PD, eds. The immunobiology of H. pylori from pathogenesis to prevention. Philadelphia, Lippincott-Raven, 1997:1-14.
22. Yamaoka Y, Kodama T, Gutierrez O, et al. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol 1999;37:2274-9.
23. Yamaoka Y, Osato MS, Sepulveda AR, et al. Molecular epidemiology of Helicobacter pylori: separation of H. pylori from East Asian and non-Asian countries. Epidemiol Infect 2000;124:91-6.
24. Nogueira C, Figueiredo C, Carneiro F, et al. Helicobacter pylori genotypes may determine gastric histopathology. Am J Pathol 2001;158:647-54.
25. Genta RM, Roboson GO, Graham DY. Simultaneous visualization of Helicobacter pylori and gastric morphology: a new stain. Hum Pathol 1994;25:221-6.
26. El-Zimaity HM, Ota H, Scott S, et al. A new triple stain for Helicobacter pylori suitable for the autostainer: carbol fuchsin/Alcian blue/hematoxylin- eosin. Arch Pathol Lab Med 1998;122:732-6.
27. El-Zimaity HM. Modified triple stain (carbol Fuchsin/Alcian blue/ hematoxylin-eosin) for the identification of Helicobacter pylori. Arch Pathol Lab Med 2000;124:1417.
28. El-Zimaity HM, Graham DY, Al-Assi MT, et al. Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis. Hum Pathol 1996;27:35-41.
29. Park CY, Kwak M, Gutierrez O, et al. Comparison of genotyping Helicobacter pylori directly from biopsy specimens and genotyping from bacterial cultures. J Clin Microbiol 2003;41:3336-8.
30. Correa P, Fox J, Fontham E, et al. Helicobacter pylori and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risks. Cancer 1990;66:2569-74.
31. Cuello C, Correa P, Haenszel W, et al. Gastric cancer in Colombia. I. Cancer risk and suspect environmental agents. J Natl Cancer Inst 1976;57:1015-20.
32. Peek RM Jr, Vaezi MF, Falk GW, et al. Role of Helicobacter pylori cagA+ strains and specific host immune responses on the development of premalignant and malignant lesions in the gastric cardia. Int J Cancer 1999;82:520-4.
33. Weston AP, Badr AS, Topalovski M, et al. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma. Am J Gastroenterol 2000;95:387-94.
34. Clark GW. Effect of Helicobacter pylori infection in Barrett's esophagus and the genesis of esophageal adenocarcinoma. World J Surg 2003;27:994-8.
35. Goodman KJ, Correa P, Tengana Aux HJ, et al. Helicobacter pylori infection in the Colombian Andes: a population-based study of transmission pathways. Am J Epidemiol 1996;144:290-9.
36. Rugge M, Russo V, Busatto G, et al. The phenotype of gastric mucosa coexisting with Barrett's oesophagus. J Clin Pathol 2001;54:456-60.
37. Cameron AJ, Lomboy CT. Barrett's esophagus: age, prevalence, and extent of columnar epithelium. Gastroenterology 1992;103:1241-5.
38. Cameron AJ. Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol Clin North Am 1997;26:487-94.
39. Dore MP, Graham DY. Ulcers and gastritis. Endoscopy 2004;36:42-7.
40. El-Omar EM, Carrington M, Chow WH, et al. The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature 2001;412:99.
41. el-Omar EM, Rabkin CS, Gammon MD, et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003;124;1193-201.
42. Ikehara Y, Nishihara S, Yasutomi H, et al. Polymorphisms of two fucosyltransferase genes (Lewis and Secretor genes involving type I Lewis antigens) are associated with the presence of anti-Helicobacter pylori IgG antibody. Cancer Epidemiol Biomarkers Prev 2001;10:971-7.
43. Kunstmann E, Hardt C, Crabtree JE, et al. Helicobocter pylori infection: CagA-specific antibodies are associated with clinical outcome, but not with HLA-class II polymorphisms of the host. Int J Med Microbiol 2003;292:537-40.
44. Rad R, Prinz C, Neu B, et al. Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J Infect Dis 2003;188:272-81.
45. Rad R, Dossumbekova A, Neu B, et al. Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut 2004;53:1082-9.